We provide you with 20 years of free, institutional-grade data for MTNB stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of MTNB. Explore the full financial landscape of MTNB stock.
Reported Date | CIK | Ticker | Type |
---|
Matinas BioPharma Holdings, Inc(NYSE MKT:MTNB)

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nano-crystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crysta...
Website: http://www.matinasbiopharma.com
Founded: 2013
Full Time Employees: 21
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about MTNB stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.